Skip to main content
Erschienen in: World Journal of Surgery 1/2018

04.08.2017 | Original Scientific Report

Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes

verfasst von: Soo Young Kim, Bup-Woo Kim, Ju Yeon Pyo, Soon Won Hong, Hang-Seok Chang, Cheong Soo Park

Erschienen in: World Journal of Surgery | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

The use of routine central compartment neck dissection surgery for papillary thyroid carcinoma (PTC) is controversial. Although macroscopic central neck lymph node metastasis (CNLN) in PTC is a poor prognostic factor correlated with increased loco-regional recurrence, the significance of microscopic metastasis to the central lymph nodes is not established. Herein, we aimed to assess the influence of the size of CNLN on disease recurrence among PTC patients.

Methods

Data from 233 patients who underwent less than total thyroidectomy with CNLN dissection in 1989–1999 were retrospectively reviewed. The patients were assigned to three groups according to the central node metastasis: no metastasis (Group I), micrometastasis (<2 mm, Group II), and macrometastasis (≥2 mm, Group III). Clinicopathological features, recurrence rate, site of recurrence, and disease-free survival (DFS) were assessed.

Results

Of the 233 patients enrolled (mean follow-up period, 16.1 years), 134 (57.5%) had no central neck metastasis, 37 (15.9%) had micrometastasis, and 62 (26.6%) had macrometastasis. Demographics and tumour variables were similar among the three groups. Recurrence rates were 12.7, 16.2, and 43.5% in Groups I, II, and III, respectively (p < 0.001). Group III had a 3.2-fold increased relative risk of recurrence and a significantly decreased DFS compared to Group I. Group III showed significantly higher rates of lateral neck nodes metastasis than Groups I and II.

Conclusions

In conclusion, macrometastasis significantly affects disease recurrence in PTC patients, whereas microscopic metastasis has only marginal effects. Macroscopic CNLN metastasis showed a significantly higher recurrence in the lateral neck node compared to micrometastasis.
Literatur
1.
Zurück zum Zitat Jung KW, Park S, Kong HJ et al (2012) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009 Cancer research and treatment. Official J Korean Cancer Assoc 44:11–24CrossRef Jung KW, Park S, Kong HJ et al (2012) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009 Cancer research and treatment. Official J Korean Cancer Assoc 44:11–24CrossRef
2.
Zurück zum Zitat Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322CrossRefPubMed Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322CrossRefPubMed
3.
Zurück zum Zitat Heller KS (2007) Do all cancers need to be treated? The role of thyroglobulin in the management of thyroid cancer: the 2006 Hayes Martin lecture. Arch Otolaryngol Head Neck Surg 133:639–643CrossRefPubMed Heller KS (2007) Do all cancers need to be treated? The role of thyroglobulin in the management of thyroid cancer: the 2006 Hayes Martin lecture. Arch Otolaryngol Head Neck Surg 133:639–643CrossRefPubMed
4.
Zurück zum Zitat Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115:3801–3807CrossRefPubMed Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115:3801–3807CrossRefPubMed
5.
Zurück zum Zitat Shaha AR (1998) Management of the neck in thyroid cancer. Otolaryngol Clin North America 31:823–831CrossRef Shaha AR (1998) Management of the neck in thyroid cancer. Otolaryngol Clin North America 31:823–831CrossRef
6.
Zurück zum Zitat Arturi F, Russo D, Giuffrida D et al (1997) Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 82(1638–164):1 Arturi F, Russo D, Giuffrida D et al (1997) Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 82(1638–164):1
7.
Zurück zum Zitat Tuttle RM (2014) Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: aggressive treatment or cautious observation? Endocrine 46:363–364CrossRefPubMed Tuttle RM (2014) Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: aggressive treatment or cautious observation? Endocrine 46:363–364CrossRefPubMed
8.
Zurück zum Zitat Mazzaferri EL (2001) Kloos RT clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463CrossRefPubMed Mazzaferri EL (2001) Kloos RT clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463CrossRefPubMed
9.
Zurück zum Zitat Ito Y, Fukushima M, Higashiyama T et al (2013) Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J 60:113–117CrossRefPubMed Ito Y, Fukushima M, Higashiyama T et al (2013) Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J 60:113–117CrossRefPubMed
10.
Zurück zum Zitat Shah MD, Hall FT, Eski SJ et al (2003) Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 113(2102–210):7 Shah MD, Hall FT, Eski SJ et al (2003) Clinical course of thyroid carcinoma after neck dissection. Laryngoscope 113(2102–210):7
11.
Zurück zum Zitat Qubain SW, Nakano S, Baba M et al (2002) Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 131:249–256CrossRefPubMed Qubain SW, Nakano S, Baba M et al (2002) Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. Surgery. 131:249–256CrossRefPubMed
12.
Zurück zum Zitat Macdonald KI, Taylor SM, Cavanagh J, et al. Level VI node size as a predictor of malignancy in papillary thyroid cancer Journal of otolaryngology - head & neck surgery = Le Journal d’oto-rhino-laryngologie et de chirurgie cervico-faciale 2010: 39; 136-141 Macdonald KI, Taylor SM, Cavanagh J, et al. Level VI node size as a predictor of malignancy in papillary thyroid cancer Journal of otolaryngology - head & neck surgery = Le Journal d’oto-rhino-laryngologie et de chirurgie cervico-faciale 2010: 39; 136-141
13.
Zurück zum Zitat Siegel RJ (1996) Surgical pathology of lymph nodes in cancer staging: routine and specialized techniques. Surg Oncol Clin North America 5:25–31 Siegel RJ (1996) Surgical pathology of lymph nodes in cancer staging: routine and specialized techniques. Surg Oncol Clin North America 5:25–31
14.
Zurück zum Zitat Haugen BR, Alexander EK, Bible KC et al (2015) American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid Official J Am Thyroid Assoc 2016(26):1–133 Haugen BR, Alexander EK, Bible KC et al (2015) American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid Official J Am Thyroid Assoc 2016(26):1–133
15.
Zurück zum Zitat Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524–531CrossRefPubMed Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524–531CrossRefPubMed
16.
Zurück zum Zitat Cranshaw IM, Carnaille B (2008) Micrometastases in thyroid cancer. An important finding? Surg Oncol 17:253–258CrossRefPubMed Cranshaw IM, Carnaille B (2008) Micrometastases in thyroid cancer. An important finding? Surg Oncol 17:253–258CrossRefPubMed
17.
Zurück zum Zitat Randolph GW, Duh QY, Heller KS et al (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid Official J Am Thyroid Assoc 22:1144–1152CrossRef Randolph GW, Duh QY, Heller KS et al (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid Official J Am Thyroid Assoc 22:1144–1152CrossRef
18.
Zurück zum Zitat Jeon MJ, Yoon JH, Han JM et al (2013) The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur J Endocrinol 168:219–225CrossRefPubMed Jeon MJ, Yoon JH, Han JM et al (2013) The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma. Eur J Endocrinol 168:219–225CrossRefPubMed
19.
Zurück zum Zitat Ellenhorn JD, Shah JP, Brennan MF (1993) Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland. Surgery 114:1078–1081 (discussion 1081-1072) PubMed Ellenhorn JD, Shah JP, Brennan MF (1993) Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland. Surgery 114:1078–1081 (discussion 1081-1072) PubMed
20.
Zurück zum Zitat Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(418–42):8 Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(418–42):8
21.
Zurück zum Zitat Institute NC A 2009 SEER Cancer Statistics Review, 1975-2006 2009 Institute NC A 2009 SEER Cancer Statistics Review, 1975-2006 2009
22.
Zurück zum Zitat Wong CK, Wheeler MH (2000) Wheeler Thyroid nodules: rational management. World J Surg 24(934–94):1 Wong CK, Wheeler MH (2000) Wheeler Thyroid nodules: rational management. World J Surg 24(934–94):1
23.
Zurück zum Zitat Onkendi EO, McKenzie TJ, Richards ML et al (2014) Reoperative experience with papillary thyroid cancer. World J Surg 38(645–65):2 Onkendi EO, McKenzie TJ, Richards ML et al (2014) Reoperative experience with papillary thyroid cancer. World J Surg 38(645–65):2
24.
Zurück zum Zitat White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31(895–90):4 White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31(895–90):4
25.
Zurück zum Zitat Teixeira G, Teixeira T, Gubert F et al (2011) The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0. Surgery 150:1161–1167CrossRefPubMed Teixeira G, Teixeira T, Gubert F et al (2011) The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged preoperatively and intraoperatively as N0. Surgery 150:1161–1167CrossRefPubMed
26.
Zurück zum Zitat Forest VI, Clark JR, Ebrahimi A et al (2011) Central compartment dissection in thyroid papillary carcinoma. Ann Surg 253:123–130CrossRefPubMed Forest VI, Clark JR, Ebrahimi A et al (2011) Central compartment dissection in thyroid papillary carcinoma. Ann Surg 253:123–130CrossRefPubMed
27.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T et al (2006) Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30(91–9):9 Ito Y, Tomoda C, Uruno T et al (2006) Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30(91–9):9
28.
Zurück zum Zitat Shimamoto K, Satake H, Sawaki A et al (1998) Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 29:4–10CrossRefPubMed Shimamoto K, Satake H, Sawaki A et al (1998) Preoperative staging of thyroid papillary carcinoma with ultrasonography. Eur J Radiol 29:4–10CrossRefPubMed
29.
Zurück zum Zitat Solorzano CC, Lee TM, Ramirez MC et al (2005) Surgeon-performed ultrasound improves localization of abnormal parathyroid glands. The American surgeon. 71:557–562 (discussion 562-553) PubMed Solorzano CC, Lee TM, Ramirez MC et al (2005) Surgeon-performed ultrasound improves localization of abnormal parathyroid glands. The American surgeon. 71:557–562 (discussion 562-553) PubMed
30.
Zurück zum Zitat Sywak M, Cornford L, Roach P et al (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000–1005 (discussion 1005-1007) CrossRefPubMed Sywak M, Cornford L, Roach P et al (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000–1005 (discussion 1005-1007) CrossRefPubMed
31.
Zurück zum Zitat Moreno MA, Edeiken-Monroe BS, Siegel ER et al (2012) In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival. Thyroid Official J Am Thyroid Assoc 22:347–355CrossRef Moreno MA, Edeiken-Monroe BS, Siegel ER et al (2012) In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival. Thyroid Official J Am Thyroid Assoc 22:347–355CrossRef
32.
Zurück zum Zitat Thomas LE, Pencina MJ (2016) Do Not Over (P) Value Your Research Article. JAMA Cardiol. 1:1055CrossRefPubMed Thomas LE, Pencina MJ (2016) Do Not Over (P) Value Your Research Article. JAMA Cardiol. 1:1055CrossRefPubMed
Metadaten
Titel
Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes
verfasst von
Soo Young Kim
Bup-Woo Kim
Ju Yeon Pyo
Soon Won Hong
Hang-Seok Chang
Cheong Soo Park
Publikationsdatum
04.08.2017
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 1/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-017-4158-5

Weitere Artikel der Ausgabe 1/2018

World Journal of Surgery 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.